chr3-10142088-C-T

Variant summary

Our verdict is Likely pathogenic.
+8 Likely Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 8 classification points (ACGS-UK Somatic Oncogenicity v2025). O1_StrongO4_SupportingO5_SupportingO6_SupportingO7_Supporting

The NM_000551.4(VHL):c.241C>T (p.Pro81Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene VHL is a tumor suppressor gene (CancerMine: 345 TSG, 114 oncogene, 46 driver citations). The gene VHL is a known oncogene (CancerMine: 345 TSG, 114 oncogene, 46 driver citations). The gene VHL is a cancer driver gene (CancerMine: 345 TSG, 114 oncogene, 46 driver citations). The variant allele was found at a cumulative frequency of 0.000353 (AC=566) in the gnomAD database across 1,605,226 control chromosomes, including 1 homozygote. The grpmax filtering allele frequency (95% CI) is 0.000534. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★★). A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.P81L: Pathogenic/Likely_pathogenic (ClinVar VariationId 36899, 2 stars) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.P81A: Uncertain_significance (ClinVar VariationId 1068142, 1 star); p.P81= (synonymous): Benign/Likely_benign (ClinVar VariationId 3468038, 2 stars); p.P81= (synonymous): Benign/Likely_benign (ClinVar VariationId 2927601, 2 stars); p.P81= (synonymous): Benign (ClinVar VariationId 4071324, 1 star) This exact variant is established as oncogenic in: CGI (Cancer Genome Interpreter). The variant has been observed in cBioPortal in 7 samples across 2 studies and 7 cancer types; somatic enrichment level: SUPPORTING (Observed repeatedly in cBioPortal somatic datasets.). This exact variant is curated in the UniProt human variants database as Uncertain Significance, associated with Von hippel-lindau syndrome (vhl); it is also listed as a COSMIC curated somatic variant.

Frequency

Genomes: 𝑓 0.00035 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00035 ( 1 hom. )

Consequence

VHL
NM_000551.4 missense

Scores

8
8
3

Clinical Significance

Benign reviewed by expert panel P:2U:12B:15

Conservation

PhyloP100: 1.47

Publications

51 publications found
Variant links:
Genes affected
VHL (HGNC:12687): (von Hippel-Lindau tumor suppressor) This gene encodes a component of a ubiquitination complex. The encoded protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. In addition to oxygen-related gene expression, this protein plays a role in many other cellular processes including cilia formation, cytokine signaling, regulation of senescence, and formation of the extracellular matrix. Variants of this gene are associated with von Hippel-Lindau syndrome, pheochromocytoma, erythrocytosis, renal cell carcinoma, and cerebellar hemangioblastoma. [provided by RefSeq, Jun 2022]
VHL Gene-Disease associations (from GenCC):
  • pheochromocytoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • von Hippel-Lindau disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, ClinGen, Genomics England PanelApp
  • renal cell carcinoma
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • autosomal recessive secondary polycythemia not associated with VHL gene
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics
  • Chuvash polycythemia
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000551.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_pathogenic. The variant received 8 points.

O1Established oncogenic variant
CGI exact DNA-change oncogenic — Strong (O1); O1 contributing sources (4.0 pts): CGI (Cancer Genome Interpreter)
O4Enriched in somatic variant database
Enriched in cBioPortal (pre-computed score ≥ 1.0) — Supporting (O4); cBioPortal: samples=7 | studies=2 | cancer types=7 | level=SUPPORTING | points=1.0 | reason: Observed repeatedly in cBioPortal somatic datasets.
O5Same location/impact as known oncogenic
Different AA at same residue with oncogenic evidence (or germline P/LP in TSG), or same AA change SCI Tier II Potential — Supporting (O5); ClinVar same-AA oncogenic/T1: false | ClinVar same-AA SCI tier: — | CGI same-AA oncogenic: false | TSG: true | ClinVar same-AA germline P/LP: false | CIViC LOF: false | ClinVar diff-AA oncogenic: false | ClinVar diff-AA germline P/LP: true
O6Computational evidence supports deleterious effect
Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect
O7Mutational hotspot or critical domain
Supporting: cancerhotspots.org hit, critical domain, or missense neighbourhood hotspot; No cancerhotspots.org hit at this position; UniProt domain: 0 pathogenic, 0 benign.; ±8 AA neighbourhood: 39 pathogenic, 6 benign (OR vs. background: 30.4); Variant does not impact splicing — splice-hotspot path not applicable

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000551.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

VHL NM_000551.4
MANE Select
HGVSc / HGVSpc.241C>Tp.Pro81Ser
Exon rankExon 1 of 3
missense
Prot: NP_000542.1UniProt: A0A024R2F2P40337-1
VHL NM_001354723.2
HGVSc / HGVSpc.241C>Tp.Pro81Ser
Exon rankExon 1 of 3
missense
Prot: NP_001341652.1UniProt: A0A8Q3WL21
VHL NM_198156.3
HGVSc / HGVSpc.241C>Tp.Pro81Ser
Exon rankExon 1 of 2
missense
Prot: NP_937799.1UniProt: P40337-2A0A0S2Z4K1

Ensembl Transcripts

VHL ENST00000256474.3
TSL:1MANE Select
HGVSc / HGVSpc.241C>Tp.Pro81Ser
Exon rankExon 1 of 3
missense
Prot: ENSP00000256474.3UniProt: P40337-1
VHL ENST00000345392.3
TSL:1
HGVSc / HGVSpc.241C>Tp.Pro81Ser
Exon rankExon 1 of 2
missense
Prot: ENSP00000344757.2UniProt: P40337-2
VHL ENST00000477538.2
TSL:1
HGVSc / HGVSpn.287C>T
Exon rankExon 1 of 3
non_coding_transcript_exon
Prot:

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.000348
AC:53
Hom:0
AN:152206
Cov:33
GnomAD2 exomes
AF: 0.000200
AC:46
AN:230188
GnomAD4 exome
AF: 0.000353
AC:513
Hom:1
AN:1453020
Cov:32
GnomAD4 genome
AF: 0.000348
AC:53
Hom:0
AN:152206
Cov:33
TOPMed (Bravo)
AF: 0.000348
AC:92
Hom:0
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.000598
AC:140
Hom:0
AN:233924
Local & regional cohorts 1 source
ESP6500 (Exome Variant Server)
AF: 0.000390
AC:5
AN:12808
Showing 7 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
ASC
(Autism)
0.000834 *89598 0.000576 *610410
BipEx
(Bipolar disorder (including schizoaffective))
0.000598 1728420 0.000381 1128844
Epi25
(Epilepsy)
0.000286 1241958 0.000449 3066888
SCHEMA
(Schizophrenia)
0.000148 18121784 0.000200 38190432
Showing 4 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
5
7
Von Hippel-Lindau syndrome (13)
-
2
5
not provided (7)
-
2
1
not specified (3)
-
1
1
Hereditary cancer-predisposing syndrome (2)
-
1
-
Chuvash polycythemia (1)
1
-
-
Enchondromatosis (1)
-
1
-
Hepatoblastoma (1)
-
-
1
Von Hippel-Lindau syndrome;C1837915:Chuvash polycythemia (1)

Computational Scores

AlphaGenome AVI
Pathogenic24
AlphaMissense
Pathogenic0.58
BayesDel_addAF
Uncertain0.050T
BayesDel_noAF
Pathogenic0.21
CADD
Benign21
DANN
Uncertain1.0
DEOGEN2
Pathogenic0.91D
Eigen
Uncertain0.23
Eigen_PC
Uncertain0.28
FATHMM_MKL
Uncertain0.87D
FuncVEP CTI
Pathogenic0.71
GPN-Star LLR
N/A-7.0
GPN-Star score
N/A7.0
LIST_S2
Uncertain0.87D
M_CAP
Pathogenic0.99D
MetaRNN
Uncertain0.55D
MetaSVM
Pathogenic0.99D
Mutation Taster
N/A7/93disease causing
MutationAssessor
Benign1.7L
PhyloP100
Benign1.5
popEVE
Benign-3.2
PrimateAI
Pathogenic0.88D
PromoterAI
N/A-0.042Neutral
PROVEAN
Uncertain-3.2D
RBP_binding_hub_radar
N/A0.0
RBP_regulation_power_radar
N/A1.7
REVEL
Pathogenic0.68
Sift
Benign0.038D
Sift4G
Benign0.39T
Varity_R
N/A0.81
VESM-3B
Benign-5.7
Showing 31 of 31 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.